The AGA Journals Blog highlights the latest discoveries in gastroenterology and hepatology research.

learning from experience

Author: Kristine Novak

Kristine Novak

Are Subcutaneous Drugs as Safe and Effective for IBD as Intravenous Drugs?

The infliximab biosimilar CT-P13 subcutaneous (SC) is non-inferior to CT-P13 intravenous (IV) in pharmacokinetics, efficacy, safety, and immunogenicity outcomes of patients with inflammatory bowel diseases

Related Posts Plugin for WordPress, Blogger...
Read More

About The Author

Dr. Kristine Novak

Dr. Kristine Novak

Dr. Kristine Novak is a science writer and editor based in San Francisco. She has extensive experience covering gastroenterology, hepatology, immunology, oncology, clinical, and biotechnology research discoveries.

Top Viewed

Share on facebook
Share on google
Share on twitter
Share on linkedin


We never use your email for anything other than The AGA Journals Blog.